ScitoVation logo
  • Services
    • Common Problems We Solve
      • Predicting Equivalent Dose in Humans
      • Understanding the Mode of Action of a Compound
      • Screening and Assessing Lead Compounds
    • Technologies
      • In vitro to in vivo extrapolation (IVIVE)
      • PBPK Modeling
      • Toxicogenomic or Pharmacogenomic Studies
    • Organ Specific
      • Liver toxicity
      • Respiratory Toxicity
      • Thyroid toxicity
    • Industries
      • Chemical Manufacturers and Consumer Products
      • Industry Associations
      • Pharma
  • Publications
  • Tools
    • MoAVIZ
    • PLETHEM
    • TTC Data Mart
  • Resources
    • Blog
    • Webinar
    • Case Studies
  • About us
    • Our Story
    • Team
    • Mission, Vision, Values
    • Careers
    • Scitovation, LLC. PHS-Financial Conflict Of Interest (FCOI) Policy
    • News
  • Request For Quote

Latest News

April 28, 2022

ScitoVation Nabs Leslie Recio, PhD DABT, as Chief Scientific Officer

Read More
March 24, 2022

ScitoVation to Release New Approach Methods (NAMs) Report at Society of Toxicology 61st Annual Meeting March 27th – 31st

Read More
Featured image for “Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling in Nanomedicine, Food Safety and Human Health Risk Assessment and Roles of Artificial Intelligence (AI) Approaches in these Areas”
November 18, 2021

Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling in Nanomedicine, Food Safety and Human Health Risk Assessment and Roles of Artificial Intelligence (AI) Approaches in these Areas

Read More
Featured image for “Chemical structure-property relationships and PBPK modeling: Progress and Perspectives”
October 29, 2021

Chemical structure-property relationships and PBPK modeling: Progress and Perspectives

Read More
Featured image for “Development of a Molecular Fingerprint for Predicting Drug-induced Cholestasis”
August 25, 2021

Development of a Molecular Fingerprint for Predicting Drug-induced Cholestasis

Read More
Featured image for “Cardiac Toxicity Evaluation with a Human Tissue-Engineered Model”
June 22, 2021

Cardiac Toxicity Evaluation with a Human Tissue-Engineered Model

Read More
Featured image for “Advancing Neurotoxicity Screening of Environmental Compounds for Public Health Protection”
May 20, 2021

Advancing Neurotoxicity Screening of Environmental Compounds for Public Health Protection

Read More
Featured image for “In Vitro Inhalation Point-of-Contact Toxicity Testing with Vapors”
April 15, 2021

In Vitro Inhalation Point-of-Contact Toxicity Testing with Vapors

Read More
April 1, 2021

ScitoVation Researcher Selected as Finalist

Read More
Prev 1 2 3 4 5 6 7 8 9 Next
Contact Us

6 Davis Drive, Suite 146,
Durham, NC 27709

© 2025 ScitoVation. Privacy Policy
  • Services
    • Common Problems We Solve
      • Predicting Equivalent Dose in Humans
      • Understanding the Mode of Action of a Compound
      • Screening and Assessing Lead Compounds
    • Technologies
      • In vitro to in vivo extrapolation (IVIVE)
      • PBPK Modeling
      • Toxicogenomic or Pharmacogenomic Studies
    • Organ Specific
      • Liver toxicity
      • Respiratory Toxicity
      • Thyroid toxicity
    • Industries
      • Chemical Manufacturers and Consumer Products
      • Industry Associations
      • Pharma
  • Publications
  • Tools
    • MoAVIZ
    • PLETHEM
    • TTC Data Mart
  • Resources
    • Blog
    • Webinar
    • Case Studies
  • About us
    • Our Story
    • Team
    • Mission, Vision, Values
    • Careers
    • Scitovation, LLC. PHS-Financial Conflict Of Interest (FCOI) Policy
    • News
  • Request For Quote